NGM Biopharmaceuticals Inc (NASDAQ:NGM)

13.54
Delayed Data
As of 3:59pm ET
 -0.20 / -1.46%
Today’s Change
10.49
Today|||52-Week Range
27.25
-23.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
AssetsCash45.5M25.6M56.9M--
 
 
 
 
Short Term Investment Cash-63.2M-19.9M31.3M--
 
 
 
 
Cash & Short Term Investments230.2M173.7M206.6M--
 
 
 
 
 
ReceivablesReceivables2.8M0.003.7M--
 
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsOther Current Assets1.7M1.8M4.3M--
 
 
 
 
Current Assets234.7M175.5M214.6M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----46.1M--
 
 
Depreciation-----22.2M--
 
 
Other Assets161.0K1.1M5.4M--
 
 
 
 
Total Assets277.0M248.9M246.1M--
 
 
 
 
 
LiabilitiesAccounts Payable8.4M1.9M5.8M--
 
 
 
 
Accrued Expenses10.2M13.6M12.5M--
 
 
 
 
Other Current Liabilities29.3M35.0M31.6M--
 
 
 
 
Other Liabilities37.7M36.9M41.5M--
 
 
 
 
 
Total LiabilitiesOther Liabilities17.9M15.4M14.0M--
 
 
 
 
Total Liabilities97.2M75.0M59.4M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock294.9M294.9M294.9M--
 
 
 
 
Common Equity-115.1M-121.0M-108.2M--
 
 
 
 
Total Shareholder Equity179.8M173.9M186.7M--
 
 
 
 
 
Share InformationCommon Shares Outstanding12.2M12.4M66.0M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.